Hydrafacial Introduces HydraScalp® with Keravive™ as Next Evolution in Scalp Health
Rhea-AI Summary
SkinHealth Systems (NASDAQ: SKIN) introduced HydraScalp® with Keravive™, a refreshed, professional, non-invasive scalp treatment using Hydrafacial’s Vortex-Fusion™ Technology and biomimetic peptides to cleanse, exfoliate and nourish the scalp.
The treatment adds newly engineered Purify™ and Nourish™ tips for better contact, suction, exfoliation and serum delivery, aiming to improve scalp health and the appearance of fuller, thicker-looking hair, with clinical findings supporting visible benefits.
AI-generated analysis. Not financial advice.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
While SKIN fell 9.15%, peers showed mixed moves: HELE -1.11%, NUS -1.23%, HNST +0.29%, EPC +2.65%, YSG +9.81%, pointing to stock-specific pressure rather than a broad sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| May 07 | Q1 2026 earnings | Negative | -36.3% | Q1 2026 results with net sales decline and lowered full-year sales guidance. |
| Apr 29 | Earnings date notice | Neutral | -3.8% | Announcement of timing and access details for upcoming Q1 2026 earnings call. |
| Apr 22 | Board changes | Positive | -8.2% | Appointment of three independent directors with operational and clinical expertise. |
| Apr 22 | Corporate rebrand | Positive | +2.2% | Rebrand to SkinHealth Systems emphasizing a clinically driven aesthetics platform. |
| Mar 12 | FY 2025 earnings | Positive | +19.8% | Full-year 2025 results with higher margins and adjusted EBITDA despite lower sales. |
Recent news has often been met with downside reactions, including earnings and governance updates, with only select branding/earnings events drawing positive moves.
Over the last few months, SKIN has reported softer sales trends but improving profitability, with 2025 net sales $300.8M and adjusted EBITDA of $45.1M, then Q1 2026 net sales of $64.9M and a lowered 2026 sales outlook. Governance changes included a corporate rebrand to SkinHealth Systems and three new independent directors. Many of these updates, including earnings and board changes, saw negative 24-hour price reactions, framing today’s scalp-treatment product refresh against a backdrop of operational and listing-compliance challenges.
Market Pulse Summary
This announcement highlights a refreshed HydraScalp with Keravive treatment, backed by clinical data showing 75% improved hair fullness and 82% reporting healthier-looking hair, plus a 6x increase in scalp hydration after one treatment. Set against recent guidance cuts and a Nasdaq minimum bid notice, investors may watch how effectively the company monetizes scalp health demand across its installed base and whether such innovations translate into stabilizing sales and margins.
Key Terms
biomimetic peptides medical
clinical findings medical
AI-generated analysis. Not financial advice.
An advanced, non-invasive scalp treatment with no downtime, featuring newly engineered tips and clinically proven to visibly improve scalp health and the appearance of fuller, thicker-looking hair
LONG BEACH, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ: SKIN), a global medical aesthetics company and home to flagship brand Hydrafacial, today announced a refresh of its clinically supported Keravive™ scalp treatment as HydraScalp® with Keravive™, marking the next evolution in its scalp health offering.
HydraScalp with Keravive is a professional, non-invasive, in-office treatment powered by Hydrafacial’s proprietary Vortex-Fusion™ Technology and Keravive biomimetic peptides to deeply cleanse, exfoliate and nourish the scalp. By removing buildup and delivering targeted key ingredients to the scalp, the treatment helps create an optimal scalp environment for fuller, healthier-looking hair.
The enhanced treatment introduces newly engineered Purify™ and Nourish™ treatment tips, designed specifically for the scalp to improve contact, suction, exfoliation, and serum delivery. Together, these advancements help enhance treatment precision, streamline provider experience, and deliver more consistent, visible scalp and hair results.
“We’re seeing a surge in demand for scalp health and hair thinning solutions, with consumers looking for options beyond over-the-counter and invasive treatments,” said Whitney Cypes, Chief Brand and Clinical Innovation Officer of SkinHealth Systems. “Our refreshed HydraScalp with Keravive treatment fills that gap, delivering a non-invasive, no-downtime experience that’s both comfortable and results-driven. By leveraging the Hydrafacial platform, we’re enabling providers to treat the scalp with the same precision and consistency as the skin.”
Consumer interest in scalp health continues to rise, with 73 percent of consumers reporting concerns related to scalp condition and hair growth, and 76 percent of those consumers expressing interest in an in-office treatment to address their concerns¹. As more consumers seek non-invasive options that support scalp health and overall hair appearance, HydraScalp with Keravive offers a zero-downtime treatment designed to help remove buildup and hydrate a dry scalp.
HydraScalp with Keravive treatment is supported by clinical findings showing²:
75% saw improved hair fullness after 8 weeks, 2 treatments and daily use of take-home peptide complex spray82% said their hair looked healthier, shinier after 3 treatments over the course of 3 months- 6 times more hydrated scalp after one treatment
- Visible reduction in skin dryness, flaking and roughness after one treatment
HydraScalp with Keravive treatments follow a three-step protocol: Purify, to remove buildup; Nourish, to hydrate the scalp with peptides and growth factor-inspired ingredients; and Boost, a daily regimen with a take-home peptide complex spray to help maintain results between treatments. HydraScalp with Keravive is available as a single treatment; for optimal results, a series of three treatments is recommended.
“We’re seeing a growing recognition that the scalp is simply an extension of your skin, and it deserves the same level of care,” said Board-Certified Dermatologist Dr. Corey Hartman. “Optimal hair health truly begins with optimal scalp health. Factors like lifestyle, environmental exposure, and even the products you use can have a major impact on your scalp health and, in turn, hair growth. Supporting the scalp through consistent cleansing and hydration helps create the right foundation for healthy hair, and treatments like the Hydrafacial HydraScalp with Keravive can help remove buildup, replenish hydration, and promote a balanced scalp environment over time.”
HydraScalp with Keravive is now available at select Hydrafacial providers nationwide. For more information and to find a provider near you, visit hydrafacial.com/find-a-hydrafacialist.
¹ NewBeauty Beauty Engine Survey, January 2026 (N=1,464)
² Skintuition Report Volume 3 from BeautyHealth, 2025
³ HydraScalp MOA Study. Preliminary Findings. Hydrafacial LLC. Data on file. 2026.
About SkinHealth Systems
SkinHealth Systems (NASDAQ: SKIN) is a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions designed to help consumers achieve superior skin health and support the success of providers. Anchored by Hydrafacial™, a leading and widely requested professional skincare treatment, and supported by complementary offerings including SkinStylus™ microneedling and HydraScalp® with Keravive™, SkinHealth Systems combines advanced device technology, proprietary consumables, and clinical validation to deliver trusted treatment experiences through an omnichannel network of providers worldwide. Learn more at skinhealthsystems.com or follow us on LinkedIn. Local providers can be found at hydrafacial.com/find-a-hydrafacialist.
Forward-Looking Statements
Certain statements made in this release are “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding SkinHealth Systems Inc.’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements.
These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside SkinHealth Systems Inc.’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.
Important factors that may affect actual results or outcomes include, among others: SkinHealth Systems Inc.’s ability to manage growth; SkinHealth Systems Inc.’s ability to execute its business plan; consumers’ perception of scalp health, scalp concerns, and overall hair health trends; the success of HydraScalp with Keravive’s launch and how its products are received amongst consumers and providers; potential litigation involving SkinHealth Systems Inc.; changes in applicable laws or regulations; the possibility that SkinHealth Systems Inc. may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 filed with the U.S. Securities and Exchange Commission (the “SEC”) and in the Company’s subsequent filings with the SEC such as on a Quarterly Report on Form 10-Q. There may be additional risks that the Company does not presently know of or that the Company currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. SkinHealth Systems Inc. does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
Contacts:
Press: jburchette@devriesglobal.com
Source: SkinHealth Systems
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/d3ae5707-5ab9-414a-aed9-8c6016bb016e
https://www.globenewswire.com/NewsRoom/AttachmentNg/9654038d-d66a-45c1-a0fa-340d4fbc35f4
